PFE
Pfizer Inc.
- Capital expenditures, 2025
- $2.6B
- YoY, 2025
- −9.6%
- 5-year CAGR
- +3.4%
- 10-year CAGR
- +6.5%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $2.6B | −9.6% |
| 2024 | $2.9B | −25.5% |
| 2023 | $3.9B | +20.7% |
| 2022 | $3.2B | +19.4% |
| 2021 | $2.7B | +21.8% |
| 2020 | $2.2B | +8.8% |
| 2019 | $2.0B | +3.1% |
| 2018 | $2.0B | +1.4% |
| 2017 | $2.0B | +7.3% |
| 2016 | $1.8B | +30.5% |
| 2015 | $1.4B | +16.5% |
| 2014 | $1.2B | −0.6% |
| 2013 | $1.2B | −9.1% |
| 2012 | $1.3B | −20.1% |
| 2011 | $1.7B | +9.7% |
| 2010 | $1.5B | +25.6% |
| 2009 | $1.2B | −29.2% |
| 2008 | $1.7B | −9.5% |
| 2007 | $1.9B | — |